Nexstim Plc's latest marketcap:
As of 08/04/2025, Nexstim Plc's market capitalization has reached $118.66 M. According to our data, Nexstim Plc is the 23665th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 118.66 M |
| Revenue (ttm) | 11.8 M |
| Net Income (ttm) | -1,030,767.63 |
| Shares Out | 7.18 M |
| EPS (ttm) | -0.15 |
| Forward PE | 29.79 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/15/2025 |
Nexstim Plc's yearly market capitalization.
| Date | Market Cap(€) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/04/2025 | €102.72 M | $118.66 M | 82.19% | 23665 |
| 12/30/2024 | €56.58 M | $58.57 M | 184.44% | 26902 |
| 12/29/2023 | €19.89 M | $21.95 M | -27.93% | 33167 |
| 12/30/2022 | €27.6 M | $29.54 M | -13.65% | 30333 |
| 12/30/2021 | €31.96 M | $36.33 M | -25.66% | 29511 |
| 12/30/2020 | €43 M | $52.51 M | 495.46% | 24426 |
| 12/30/2019 | €7.22 M | $8.1 M | 269.24% | 29500 |
| 12/28/2018 | €1.96 M | $2.24 M | -92.37% | 31218 |
| 12/29/2017 | €25.62 M | $30.73 M | 259.54% | 23856 |
| 12/30/2016 | €7.13 M | $7.49 M | -84.52% | 26003 |
Company Profile
About Nexstim Plc
Nexstim Plc is a Finland-based medical technology company specializing in non-invasive brain stimulation technologies. Operating across Europe, North America, and internationally, the company focuses on innovative neuromodulation solutions.
Core Technology
The company's flagship technology is transcranial magnetic stimulation (TMS), a non-invasive technique that uses electromagnetic pulses to target and interact with specific brain regions externally.
Key Products
- Navigated Brain Stimulation (NBS) 5 System – A TMS system for pre-surgical mapping of the motor cortex and speech areas.
- NBS 6 & NBT Systems – Navigated brain therapy systems for treating major depressive disorder and chronic neuropathic pain.
Market & Collaborations
Nexstim markets its diagnostic systems to universities and teaching hospitals. The company has strategic partnerships, including:
- An exclusive collaboration with Sinaptica Therapeutics, Inc. to develop precision neuromodulation devices.
- A development and distribution partnership with Brainlab AG for non-invasive brain mapping solutions.
Founded: 2000 | Headquarters: Helsinki, Finland
Frequently Asked Questions
-
What is Nexstim Plc's (HEL-NXTMH) current market cap?As of 08/04/2025, Nexstim Plc (including the parent company, if applicable) has an estimated market capitalization of $118.66 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Nexstim Plc (HEL-NXTMH) rank globally by market cap?Nexstim Plc global market capitalization ranking is approximately 23665 as of 08/04/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.